Anti-Human PLA2G7 Therapeutic Antibody scFv Fragment (B38.2)

Recombinant monoclonal antibody B38.2 is a mouse monoclonal antibody that specifically binds to human Lp-PLA2 and can be potentially used in the treatment of coronary vascular disease.
Supplier Creative Biolabs
Product # TAB-0695CL-S(P)
Pricing Inquiry
Applications ELISA
Host Mouse
Target Lp-PLA2 (Lipoprotein-associated phospholipase A2)
Feedback